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The importance of basing health policy and health care practices on the best available international evidence (“evidence-based
healthcare”)andontranslatingknowledgeorevidenceintoaction(“translationscience”or“translationalresearch”)isincreasingly
being emphasized across all health sectors inmost countries. Evidence-based healthcare is a process that identiﬁes policy or clinical
questions and addresses these questions by generating knowledge and evidence to eﬀectively and appropriately deliver healthcare
in ways that are eﬀective, feasible, and meaningful to speciﬁc populations, cultures, and settings. This evidence is then appraised,
synthesized, and transferred to service delivery settings and health professionals who then utilize it and evaluate its impact on
health outcomes, health systems, and professional practice. Many of the common theories that address this translational process
place it apart from the evidence-based practice cycle and most recognise only two translational gaps. This paper seeks to clarify
the nature of evidence-based healthcare and translation science and proposes a reconceptualization that both brings together these
two dominant ideas in modern healthcare and asserts the existence of a third fundamental gap that is rarely addressed the gap
between knowledge need and discovery.
1.Introduction
The challenges related to facilitating the cycle of scientiﬁc
discoverythroughtothewidespreadadoptionofahealthcare
innovation have become of central concern to individuals
and communities who seek or need healthcare; health
professionals; policy makers; the funders of health services.
Indeed, the interface between identifying knowledge needs
for health improvement, pure scientiﬁc bench research, clin-
ical trial based research, and, ultimately, the implementation
of the results of research into some form of pragmatic
outcome is a growing source of ongoing angst in both the
research and clinical communities. It is a vital enterprise
that, if achieved successfully, has the potential to result in
dramatic improvements in global health outcomes. Whilst
the translation of evidence into action is the raison d’ˆ etre
of the evidence-based practice movement, so, too, is it the
core interest of translation science. Clarifying the nature
and components of these two seemingly diﬀerent (but,
in our view, clearly complimentary) ﬁelds of endeavour
and reconceptualizing this complementarity is important in
advancing health policy and practice towards improving the
health of people globally.
Nursing in central to the delivery of healthcare and an
increasingly major contributor to the evidence-based prac-
tice movement broadly and the achievement of evidence-
based practice in healthcare settings. Although the origins
of evidence-based practice are in medicine, nursing is
increasingly playing a role, particularly with respect to
aligning practice with evidence at the point of care. Nurse
scientists, therefore, are well positioned to take a leadership
role in the ﬁeld of translational science.
2.ClarifyingandReconceptualizing
Evidence-BasedHealthcare
There are a number of models that attempt to represent
the components of evidence-based healthcare to facilitate2 Nursing Research and Practice
understanding, analysis, improvement, and/or the replace-
ment of the process as it is currently conceived, purported
andpracticed,forexample,theAceStarModelofKnowledge
Transformation [1]; the ﬁve stage model of evidence-based
healthcare [2]; the work of Titler and Everett [3]; the
Stetler Model of Research Utilization [4–7]. Dobrow et al.
[8] have developed a conceptual framework for evidence-
based decision making, and Pearson et al. [9] report on the
development of the JBI model of evidence-based healthcare
(JBI Model).
2.1. The JBI Model. The JBI Model is developmental and,
building on frameworks that have evolved, was constructed
out of experience within the evidence-based practice ﬁeld;
the emerging international work of the Joanna Briggs
Institute and the international Collaborating Centers of the
Joanna Briggs Collaboration; involvement in disseminating,
implementing and evaluating evidence-based guidelines in
clinical settings; an examination of the scientiﬁc and profes-
sional literature.
Evidence-based practice can be conceptualized as clinical
decision making that considers the best available evidence;
the context in which the care is delivered; client preference;
and the professional judgment of the health professional.
The JBI model of evidence-based healthcare depicts the four
major components of the evidence-based healthcare process
as:
(i) healthcare evidence generation;
(ii) evidence synthesis;
(iii) evidence/knowledge transfer;
(iv) evidence utilization.
Each of these components is modelled to incorporate
their essential elements, and the achievement of improved
global health is conceptualized as both the goal or endpoint
of any or all of the model components and the raison d’ˆ etre
and driver of evidence-based healthcare (Figure 1).
Evidence-based healthcare is described as a cyclical
process that derives questions, concerns, or interests from
the identiﬁcation of global healthcare needs by clinicians
or patients/consumers and then proceeds to address these
questions by generating knowledge and evidence to eﬀec-
tively and appropriately meet these needs in ways that are
eﬀective, feasible, and meaningful to speciﬁc populations,
cultures, and settings. This evidence is then appraised,
synthesized, and transferred to service delivery settings and
health professionals who then utilize it and evaluate its
impact on health outcomes, health systems, and professional
practice.
The term “evidence” is used in the model to mean the
substantiation or conﬁrmation that is needed in order to
believe that something is true [10]. Health professionals
seek evidence to substantiate the worth of a very wide
range of activities and interventions and thus the type of
evidence needed depends on the nature of the activity and
its purpose. The model depicts the process that the Joanna
Briggs Institute uses to frame the provision of the best
available evidence as well as utilization resources for health
professionals to improve global health.
2.2. Evidence-Based Practice. Central to the JBI understand-
ing of evidence-based practice is that health professionals
will use research evidence together with the context of care,
patient/client values and preferences, and the experience,
expertise, and clinical judgment of the health professional.
Using all of this information, health professionals are in a
position to make evidence informed decisions.
2.3. Global Health. The model is premised on the belief
that global health issues are both the driver and reason
for evidence-based practice. The US Institute of Medicine
(IOM) describes global health as “the goal of improving
health for all people in all nations by promoting wellness and
eliminating avoidable disease, disability, and death” [11]. For
thepurpose ofthispaper,globalhealthissuesaredetermined
to be those as identiﬁed by health professionals working at
thepointofcareorpatientsandconsumersofhealthservices.
Theseissuesareaddressedthroughthegenerationofresearch
evidence related to eﬀectiveness, appropriateness, feasibility
and meaningfulness for speciﬁc populations, cultures and
settings.
The JBI model assumes that the raison d’ˆ etre of the re-
search enterprise is to address unmet needs for knowl-
edge; that is, to identify and address concerns that arise
out of the experiences of patients/clients, the users of
healthcare, healthcare professionals, and families, carers, and
communities to generate evidence that will eﬀectively and
appropriately meet these identiﬁed needs [9].
2.4. Healthcare Evidence Generation. The model asserts that
evidence may derive from experience, expertise, inference,
deduction, or the results of rigorous inquiry but recognizes
that “the results of well-designed research studies grounded
in any methodological position are seen to be more cred-
ible as evidence than anecdotes or personal opinion” [9].
However, when no research evidence of this level exists,
other evidence may represent the “best available evidence”
for a speciﬁc question. This position is taken to provide
the most meaningful and useful information to inform
healthcaredelivery.TheJBImodelalsorecognizesthathealth
professionals consider evidence broader than evidence of
eﬀectiveness to inform their everyday practice [9] and that
they are interested in evidence of feasibility, appropriateness,
meaningfulness and/or eﬀectiveness (FAME). Feasibility is
the extent to which an activity is practical and practicable;
appropriatenessrelatestotheextenttowhichanintervention
or activity ﬁts with or is apt in a situation; meaningfulness
refersto how anintervention or activity is experienced by the
patient; eﬀectiveness is the extent to which an intervention,
when used appropriately, achieves the intended eﬀect [9].
2.5. Evidence Synthesis. Evidence synthesis is the evaluation
or analysis of research evidence and opinion on a speciﬁc
topic to aid in decision making in healthcare. Although the
science of evidence synthesis has developed most rapidlyNursing Research and Practice 3
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Figure 1: The JBI Model of Evidence-Based Healthcare [9].
in relation to the meta-analysis of numerical data linked
to theories of cause and eﬀect, the further development of
theoretical understandings and propositions of the nature
of evidence, and its role in healthcare delivery and the
facilitation of improved global health is identiﬁed as an
important element of this component of the model. Simi-
larly, the increasing, ongoing interest and theoretical work
onmethodsofsynthesizingevidencefromdiversesourcesare
depicted as an element of evidence synthesis.
The third element of evidence synthesis is the opera-
tionalization of methods of synthesis through the systematic
review process. This element in the model is grounded
in the view that evidence of feasibility, appropriateness,
meaningfulness, eﬀectiveness, and economics are legitimate
foci for the systematic review process; and that diverse forms
of evidence (from experience, opinion, and research that
involves numerical and/or textual data) can be appraised,
extracted, and synthesized [12].
There are three elements of synthesis in the model:
theories that underpin synthesis, synthesis methodologies
and the systematic review of evidence.
2.6. Evidence Transfer. This component of the model relates
to the act of transferring evidence (knowledge) to individual
health professionals, health facilities, and health systems
globally by means of journals, other publications, guidelines,
electronic media, education and training, and decision
support systems. Evidence transfer is seen to involve more
than disseminating or distributing information and should
include careful development of strategies that identify target
audiences—such as clinicians, managers, policymakers and
consumers—and methods to package and transfer infor-
mation that is understood and used in decision mak-
ing. The model therefore depicts three major elements
of evidence/knowledge transfer—education and training,
information delivery, and the transfer of evidence though
organizational and team systems. [9].
2.7. Evidence Utilization. This component of the model
relates to the implementation of evidence into practice, as
is evidenced by practice and/or system change. It identiﬁes
three elements: evaluating the impact of the utilization of4 Nursing Research and Practice
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evidence on the health system, the process of care and health
outcomes; practice change; embedding evidence through
system/organizational change.
The JBI Model of evidence-based healthcare adopts a
pluralistic approach to the notion of evidence whereby
the ﬁndings of qualitative research studies are regarded as
rigorously generated evidence and other text derived from
opinion, experience, and expertise is acknowledged as forms
of evidence when the results of research are unavailable.
Pearson and Jordan [13] say “While considerable work is
beingundertakeninternationallywithregardtotranslational
research, an inclusive approach that accounts for all elements
of the research cycle is yet to be developed and implemented
in a systematic way in many countries”. They go on to link
addressing these three gaps with the JBI model of evidence-
based healthcare (JBI Model) described by Pearson et al. [9].
3.ClarifyingandReconceptualizing
Translation Science
The Agency for Healthcare Research and Quality (AHRQ) in
the United States report to congress stated that, “the ultimate
goal (of AHRQ) is research translation—that is, making sure
that ﬁndings from AHRQ research are widely disseminated
and ready to be used in everyday healthcare decision mak-
ing.” In 1999, AHRQ published its ﬁrst Translating Research
into Practice (TRIP) initiative. The purpose of the TRIP
initiative was to generate new knowledge about approaches
that promote the utilization of rigorously derived evidence
to improve patient care. The Agency’s goal was to enhance
the use of research ﬁndings, tools, and scientiﬁc information
that would work in diverse practice settings, among diverse
populations, and under diverse payment systems [14]. The
need to improve the translation of basic and fundamental
researchﬁndingsintoroutineclinicalpracticewasalsooneof
the main observations of the “Review of UK Health Research
Funding” [15].
Knowledge translation has been seen as the process from
basic discovery (basic/laboratory science) to intervention de-
velopment (clinical trials) [16, 17], known as gap 1, transla-
tion1,orT1;development(proveninterventions)todelivery
( u s e di np r a c t i c e )[ 17, 18], known as gap 2, translation 2, T2,
or the know-do gap (Figure 2)[ 16, 18]. These gaps are two
major obstacles in knowledge translation [17].
Mode 1 and Mode 2 knowledge have been used to
describe diﬀerent ways of knowledge generation. Whereas
“Mode 1 relates to the traditional paradigm of scientiﬁc
discovery” [19, page 225]. Mode 2 involves active involve-
ment and collaboration of all stakeholders in terms of
methodologicaldevelopmentrelatedtohowtocommunicate
knowledge and how to articulate the research questions.
Mode 2 knowledge is seen as reﬂexive and transdisciplinary
[19].
The notion of translation gaps in the research-into-
action cycle is common in all of the work in progress in-
ternationally, and Pearson and Jordan [13] suggest that
there are essentially three critical gaps associated with the
translation of research into action to improve outcomes and
services (Figure 3).
3.1. Gap 1—From Knowledge Need to Discovery. The ﬁrst gap
relates to the gap between “knowledge needs” (as identiﬁed
by patients, the community, clinicians, governments, and
organizations) and the work undertaken by scientists and
researchers during the “discovery” process. Within this gap
there can be an integrated approach to topic selection, where
there is active collaboration between those conducting the
research and the end users of research (clinicians, patients,
community). This gap is a vital component of translational
research and is well addressed by very few groups, a notable
exception being the National Institute for Health Research in
the UK, with its associated Clinical Research Networks and
its community engagement program “INVOLVE.”
3.2. Gap 2—From Discovery to Clinical Application. The
second commonly identiﬁed gap relates to the gap between
what is referred to here as “discovery research” (theoretical,
epidemiological, or “bench” style research) and “clinical
research” (experimental trials including but not limited to
drug trials). This gap is the most commonly addressed
gap on the international stage with signiﬁcant work being
undertaken in many countries; but for most, this is where
translational research begins and ends.
3.3. Gap 3—From Clinical Application to Action. The third
translation gap, that of translating research into practice, is
rarely represented by strong programs in most countries,
although some have recently ventured into this realm,
notably in cardiology and metabolic/human nutrition cen-
ters.
Translating knowledge into action within healthcare is
a complex, evolving, and dynamic process. While various
models have been described, an accepted standard approach
has yet to be widely adopted. Regardless of the model used, it
is clear that three main gaps exist:
(1) the gap between the need for knowledge and the
discovery of that new knowledge;
(2) the gap between the discovery of new knowledge and
the clinical application of that knowledge;
(3) the gap between the clinical application and the
development of routine clinical actions or policy.Nursing Research and Practice 5
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Figure 4: The relationship between the translation science cycle and evidence-based healthcare.
Pearson and Jordan [13], Pearson et al. [9, 20]a n d
Pearson etal. [21], in drawing on the emerging literature,
examine the relationship between the translation science
cycle and evidence-based healthcare and suggest that the two
processes are closely related and are complementary to each
other.
4.ClarifyingandReconceptualizing
the Relationship between Evidence
Based-Healthcare andTranslationScience
Pearson et al. [21] assert that the three translation gaps and
the elements of the JBI model complement each other in
modelling the relationship between the translation science
cycle and the pragmatic evidence-based healthcare cycle
(Figure 4).
The gap between the need for knowledge and discovery
(gap 1) equates with the elements in the JBI Model that focus
on the state of global health and the generation of knowledge
through the conduct of basic or discovery-oriented research.
Applying the ﬁndings of discovery research to the “real-
world”(gap2)throughtheconductofclinicalresearch(both
trials and other health-related research including program
evaluation and qualitative inquiry) is also a component
of evidence generation. Evidence synthesis, transfer, and
utilization in the JBI model represent the processes that most
adequately address the gap between clinical application and
clinical or policy action (gap 3).
5. Conclusion
Although evidence-based healthcare is gaining acceptance
globally, it is complex, sometimes misunderstood, and6 Nursing Research and Practice
frequently maligned. The sources of evidence accessed by
practitioners, regardless of its nature—numerical, qualita-
tive, or anecdotal—or its focus—feasibility, appropriate-
ness, meaningfulness, or eﬀectiveness—inﬂuences health-
care practice in all disciplines. Research evidence that is
rigorously generated, regardless of design, demands due
consideration of its quality prior to its utilization in the
clinical environment. Evidence that is generated through
the conduct of clinical trials; epidemiology; observational
studies; qualitative studies; and action-oriented research are
essential in addressing the knowledge and evidence needs
of individuals and communities and of clinical and policy
decision makers [20].
The JBI model of evidence-based healthcare emphasizes
the need for the generation, synthesis, transfer, and utiliza-
tion of evidence derived from diverse research approaches;
has been constructed to facilitate reasoning and critique
about evidence-based healthcare and its role in improving
global health, within a logical conceptual framework.
Translation science (or translational research) is as
complexandasfrequentlymisunderstoodasevidence-based
healthcare. The dominant view of translation science overly
emphasises the translation of the results of “basic,” “bench,”
or discovery research into clinical application through the
conduct of clinical trials—an enterprise that is now well
entrenched in most advanced economies. We contend that
translation is much more than the conduct of clinical trials
to test discoveries. It begins with translating the questions
that arise out of the need for knowledge in the “real world”
into discovery research (addressing what we describe as
gap 1); translating the ﬁndings of discovery research into
clinical or policy application through clinical or policy
research (addressing what we describe as gap 2); translating
the ﬁndings of clinical or policy research into action at
the clinical or policy level (addressing what we describe
as gap 3). Integrating these three translation gaps into a
model of evidence based health appears, to us, to clarify
and reconceptualize the complexities of improving health
outcomes through translating knowledge into action.
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